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Foxp3 is crucial for both the development and
function of regulatory T (Treg) cells; however, the
posttranslational mechanisms regulating Foxp3
transcriptional output remain poorly defined. Here,
we demonstrate that T cell factor 1 (TCF1) and
Foxp3 associates in Treg cells and that active Wnt
signaling disrupts Foxp3 transcriptional activity. A
global chromatin immunoprecipitation sequencing
comparison in Treg cells revealed considerable
overlap between Foxp3 and Wnt target genes. The
activation of Wnt signaling reduced Treg-mediated
suppression both in vitro and in vivo, whereas
disruption of Wnt signaling in Treg cells enhanced
their suppressive capacity. The activation of effector
T cells increased Wnt3a production, and Wnt3a
levels were found to be greatly increased in mono-
nuclear cells isolated from synovial fluid versus
peripheral blood of arthritis patients. We propose a
model in which Wnt produced under inflammatory
conditions represses Treg cell function, allowing a
productive immune response, but, if uncontrolled,
could lead to the development of autoimmunity.
INTRODUCTION
Regulatory T (Treg) cells are a specific CD4+CD25+Foxp3+ T cell
lineage that are crucial for the induction of self-tolerance (Khattri
et al., 2003; Fontenot et al., 2003). The Forkhead box transcrip-
tion factor Foxp3 has been demonstrated to be uniquely required298 Immunity 39, 298–310, August 22, 2013 ª2013 Elsevier Inc.for Treg cell differentiation and function (Khattri et al., 2003;
Fontenot et al., 2003). Although Foxp3+ Treg cells are potent
suppressors of immune responses, and large numbers of
Foxp3+ Treg cells are often found at inflammatory sites in a
variety of diseases, including inflammatory bowel disease, type
1 diabetes, multiple sclerosis, systemic lupus, and juvenile
idiopathic arthritis (Lindley et al., 2005; Viglietta et al., 2004;
Ehrenstein et al., 2004). These findings suggest that, in many
autoimmune diseases, Treg cell function may be suppressed
by the local inflammatory environment, potentially because of
deregulated Foxp3 transcriptional activity.
It has been proposed that the association of Foxp3 with
additional transcription factors including NFAT and AML1/
Runx1 is essential for Treg-cell-suppressive function (Wu et al.,
2006; Ono et al., 2007). Both NFAT and AML1 bind to the pro-
moter of Foxp3 transcriptional targets, including the genes
encoding IL-2, CTLA-4, and CD25. Specific mutations in Foxp3
were shown to disrupt the Foxp3-NFAT or Foxp3-AML1 associ-
ation and impaired Treg-cell-mediated suppression as a result
(Wu et al., 2006; Ono et al., 2007).
In an unbiased screen for indentifying modulators of Foxp3
transcriptional activity, we identified the transcription factor
T cell factor 1 (TCF1) as a Foxp3 interaction partner. TCF1 is a
key transcription factor responding to canonical Wnt signaling
and acts as a transcriptional activator in the presence of b-cate-
nin (Staal et al., 2008; Verbeek et al., 1995). b-catenin protein
amounts are regulated by a multimolecular destruction complex
containing: axis inhibition protein (AXIN), adenomatous polypo-
sis coli, casein kinase 1 (CK1), and glycogen synthase kinase
3b (GSK3b). In the absence of Wnt signaling, b-catenin is phos-
phorylated by CK1 and GSK3b, subsequently resulting in the
polyubiquitination and degradation of b-catenin by the 26S
proteasome. The interaction of Wnt with frizzled (FZD) receptor
results in the inhibition of GSK3 activity, inactivating the
Figure 1. TCF1 Associates with Foxp3 in Human Treg Cells
(A) HA-Foxp3 was immunoprecipitated from HA-Foxp3-transfected HEK 293T
cell lysate. Specific biotin-labeled transcription factor binding sites were
added, washed, boiled, and hybridized on the TF-TF interaction array. Bound
oligos were visualized with streptavidin antibodies.
(B) HEK 293T cells were cotransfected with FLAG-Foxp3 and TCF1. Lysates
were treated with 100 U/ml DNase or 25 mg/ml EtBr for 20 min, Foxp3 was
immunoprecipitated, and immunoblots were analyzed with antibodies against
TCF1 or HA.
(C) Foxp3-TCF1 interaction in human Treg cells was visualized with an in situ
proximity ligation assay (PLA). Cells were fixed, and protein-protein in-
teractions were visualizedwith antibodies directed against Foxp3 and TCF1 as
described in the Experimental Procedures. Punctate staining (green) indicates
Foxp3-TCF1 interaction as detected by the assay. Nuclei were stained with
DAPI. Results depicted are representative of at least three independent
experiments.
See also Figure S1.
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Wnt Signaling Impairs Regulatory T Cell Functiondestruction complex and, thus, rapidly increasing b-catenin pro-
tein levels (Staal et al., 2008; Aberle et al., 1997; Reya et al., 2003;
Verbeek et al., 1995).
Within the immune system, Wnt signaling has traditionally
been studied during lymphocyte development or in the context
of hematopoietic stem cell biology (Staal et al., 2008; Verbeek
et al., 1995; Reya et al., 2003). Here, we demonstrate that theWnt-b-catenin-TCF1 module also has an unexpected role as a
regulator of Treg cell function.
RESULTS
TCF1 Associates with Foxp3 in Treg Cells
In an unbiased approach to globally identify transcription
factors associating with Foxp3, a transcription factor interaction
(TF-TF) array was performed (Figure S1A available online; see
the Experimental Procedures). The array analysis revealed the
association of a member of the Wnt-associated transcription
factor TCF family with Foxp3 (Figure 1A). This was confirmed
by coimmunoprecipitation analysis with lysates of cells ectopi-
cally expressing TCF1 and Foxp3 (Figure 1B, lane 3). TCF1
was found to interact with Foxp3 irrespectively of DNase or
EtBr treatment of the lysates, indicating that this association
was a protein-protein interaction and not a DNA-mediated
interaction (Lai and Herr, 1992). First, we confirmed that com-
ponents of the Wnt signaling cascade (TCF1, b-catenin, and
FZD receptors) were expressed in human Treg cells (Figures
S1B–S1D). To evaluate whether endogenous Foxp3 and TCF1
also associate in human Treg cells, we performed an in situ
proximity ligation assay (PLA; see the Experimental Procedures).
Given that a PLA signal can only be obtained when proteins
are in close proximity, this technique enables the detection of
direct protein-protein interactions in cells. The association of
TCF1 with Foxp3 was detected specifically in the Treg cell
nucleus (Figure 1C).
TCF1 Activation Impairs Foxp3 Transcriptional Activity
TCF1 is a key transcription factor that is regulated by canonical
Wnt signaling and acts as a transcriptional activator in the pres-
ence of b-catenin. To assess whether Wnt signaling modulates
Foxp3 transcriptional activity, we used human induced Treg
(iTreg) cells to allow for sufficient cell numbers. The iTreg cells
used were CD4+CD25high and Foxp3+, CTLA-4+, and GITR+
(Figure S2A). To manipulate Wnt signaling in Treg cells, we
used BIO, a GSK3 inhibitor widely used to mimic the activation
of the Wnt signaling cascade (Sato et al., 2004). Indeed, treat-
ment of human iTreg cells with the Wnt-mimetic BIO resulted
in a dose-dependent increase in b-catenin levels and nuclear
translocation (Figures S2B–S2D). To assess Foxp3 transcrip-
tional activity in Treg cells, we used the canonical Foxp3 tran-
scriptional target IL-2 as a readout, given that Foxp3 has been
reported to directly inhibit IL2 transcription through promoter
binding (Marson et al., 2007; Wu et al., 2006; Gavin et al.,
2007). To investigate whether TCF could modulate IL2 transcrip-
tion, we treated human Treg cells with BIO. Messenger RNA
(mRNA) expression of Axin-2, a ubiquitous TCF1 transcriptional
target, was increased, confirming that treatment with BIO
indeed activated the Wnt signaling cascade (Figure S2E). BIO
treatment of Treg cells also resulted in significantly increased
IL-2 mRNA expression (Figure 2A). Foxp3 mRNA expression re-
mained unchanged, demonstrating that this increase occurs
independently of changes in Foxp3 expression (Figure S2E).
Similarly, intracellular IL-2 protein levels and IL-2 concentrations
in the supernatant were significantly increased in mouse and
human Treg cells treated with BIO (Figure 2B–2D). Similarly,
expression levels of CD25, which are transcriptionallyImmunity 39, 298–310, August 22, 2013 ª2013 Elsevier Inc. 299
Figure 2. TCF1 Activation Impairs Foxp3
Transcriptional Activity
(A) qRT-PCR analysis of IL-2 mRNA expression in
human iTreg cells after incubation with BIO (1 mM)
for 18 hr.
(B and C) Freshly isolated mouse splenocytes (B)
or human PBMCs (C) were cultured in the pres-
ence of anti-CD3 and BIO (1 mM) or MeBIO (1 mM)
for 18 hr and stimulated with phosphomolybdic
acid and ionomycin for 4 hr, and the percentage of
Foxp3+ Treg cells that was IL-2+ was determined
by FACS analysis.
(D) Human iTreg cells were cultured for 18 hr in the
presence of anti-CD3/28-coated beads (1:100
beads to cells) in the presence of BIO (1 mM) or
MeBIO (1 mM). Supernatants were analyzed for
IL-2 levels with multiplex technology.
(E) HEK 293T cells were transfected with an IL2
promoter luciferase reporter construct, NFAT, and
Renilla. Cells were treated with GSK3 inhibitors in
order to activate TCF; LiCl (10 mM), SB 216763
(10 mM), BIO, and MeBIO (800 nM) were used as
controls.
(F) IL2 promoter activity was analyzed as in (E),
cells were cotransfected with b-catenin and TCF1,
and luciferase activity was measured.
(G) IL2 promoter activity was analyzed in cells
cotransfected with b-catenin and Foxp3.
(H) Protein-DNA interaction was analyzed with
an oligonucleotide pull-down assay. Lysates of
TCF1- or Foxp3-transfected cells were incubated
with biotin-labeled oligonucleotide probes con-
taining the TCF and Foxp3 binding site in the
human IL2 promoter. Association was visualized
with specific antibodies. B.S., binding site; IP,
immunoprecipitation; WB, western blot. Results
depicted are representative of at least three in-
dependent experiments. Mean + SEM is depicted.
See also Figure S2.
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Figure 3. b-Catenin and Foxp3 Share
Genomic Binding Sites in Treg Cells
(A) Chromatin immunoprecipitation (ChIP) was
applied in order to determine the occupancy of the
IL-2 promoter by TCF1, b-catenin, and Foxp3 in
human Treg cells pooled from five independent
donors treated with BIO (1 mM) or MeBIO (1 mM) for
4 hr. Enrichment relative to IgG control IP samples
was determined by qRT-PCR with IL-2-promoter-
specific primers.
(B) A heat map of b-catenin and Foxp3 signal
intensity in 5,000 bp distance from the center of
b-catenin peaks. Each row in the heat map cor-
responds to the single b-catenin peak. Peaks were
sorted according to Foxp3 signal intensity. Each
sample was normalized separately to maximum
yellow color intensity corresponding to the 0.95th
percentile of the read density distribution.
(C) Peak coordinates were compared to the
peak coordinates of a human Treg cell Foxp3
ChIP-seq database. The distance of overlapping
and nonoverlapping peaks to the closest anno-
tated TSS is depicted.
(D) Overlap of genes bound by b-catenin and
Foxp3.
(E) Overlap of genes regulated by BIO in human
Treg cells and genes regulated by Foxp3.
(F) Percentage of BIO upregulated genes (from
the microarray experiments) in Foxp3- and/or
b-catenin (b-cat)-bound genes. All, all genes on
the array with a mouse ortholog; IP, immunopre-
cipitation; TSS, transcription start site. Mean +
SEM is depicted.
See also Figure S3.
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with BIO (Figure S2F).
To determine whether TCF1 can directly regulate IL2 promoter
activity, we treated IL2 promoter reporter cells with three chem-
ically distinct GSK3 inhibitors in order to increase b-catenin
levels, thereby activating endogenous TCF. All three Wnt
mimetics significantly increased IL2 promoter activity to a
similar degree, whereas the MeBIO negative control had no
effect (Figure 2E). Increasing the amount of BIO resulted in a
dose-dependent increased IL2 promoter activity (Figure S2G).
In addition, IL2 promoter activity was increased by the ectopic
expression of TCF1 and b-catenin (Figure 2F). Foxp3 could
significantly repress IL2 promoter activity, as previously reported
(Figure 2G) (Marson et al., 2007; Gavin et al., 2007). However,
IL2 promoter activity was unchanged when both Foxp3 and
b-catenin were transfected, indicating that increased b-catenin
levels can override Foxp3-mediated suppression of IL2 pro-
moter activity. Given that TCF1 activation resulted in increased
IL2 promoter activity, we analyzed TCF1 and Foxp3 occupancy
of the IL2 promoter with an oligonucleotide pull-down assay.Immunity 39, 298–310Lysates of TCF1- or Foxp3-transfected
cells were incubated with biotin-labeled
oligonucleotide probes containing the
predicted TCF and Foxp3 binding site in
the human IL2 promoter, and association
was visualized by immunoblotting. BothTCF1 and Foxp3 specifically associated with the IL-2 promoter
probe (Figure 2H). Altogether, these data demonstrate that
TCF1 activation impairs Foxp3 transcriptional activity.
b-Catenin and Foxp3 Share Common Genomic Binding
Sites in Treg Cells
Using chromatin immunoprecipitation (ChIP), we determined
whether TCF1, its coactivator b-catenin, and Foxp3 could
co-occupy the IL2 promoter in human Treg cells and whether
this association was affected by the activation of Wnt signaling.
Quantitative RT-PCR (qRT-PCR) analysis demonstrated that
TCF1, b-catenin, and Foxp3 all associate with the IL2 promoter
(Figure 3A). In addition, BIO treatment resulted in a more than
3-fold increase in the amount of b-catenin associating with the
IL2 promoter. To validate these findings and to determine the
overlap of b-catenin and Foxp3 genomic binding loci, we per-
formed ChIP-seq analysis for b-catenin in human Treg cells. In
total, we identified 3,134 b-catenin-bound regions, of which
one-third were located within 1 kb of annotated transcriptional
start sites (TSS; Figure S3A). Gene ontology analysis of genes, August 22, 2013 ª2013 Elsevier Inc. 301
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displayed a significant enrichment for biological processes,
which are associated with T cell function and genes that result
in abnormal T-cell-related phenotypes in mice (Figures S3B
and S2C).
Notably, 46% of the identified b-catenin-bound regions were
located within 1 kb from the published datasets of Foxp3 peaks,
indicating a large overlap between b-catenin and Foxp3 target
genes, suggesting the coregulation of transcriptional targets
(Figure 3B) (Birzele et al., 2011). Moreover, whereas unique
b-catenin binding events are located relatively far from the
TSS, the overlapping peaks were located close to the TSS,
further supporting a functional role in gene transcription for the
association of these two factors in Treg cells (Figure 3C). In line
with this, we found a large overlap in b-catenin- and Foxp3-
bound genes (Figure 3D), suggesting that many transcriptional
targets of Foxp3 can be coregulated by b-catenin/TCF1. To
gain further insight into the mechanism behind this interplay
between Foxp3 and Wnt signaling, we used BIO to activate the
Wnt signaling pathway in human Treg cells, and gene expression
was evaluated by complementary DNA (cDNA) microarray
analysis. Subsequently, BIO-regulated genes were compared
to human orthologs of a published dataset of Foxp3-regulated
genes (Marson et al., 2007). Approximately 34% of Foxp3-regu-
lated genes were also found to be regulated by Wnt signaling in
Treg cells (Figure 3E). Next, we analyzed whether the genes
bound by Foxp3 and/or b-catenin were also transcriptionally
regulated by BIO. Of the genes bound by Foxp3 and b-catenin,
26% were regulated by BIO; in contrast, only 13% of the
genes bound exclusively by Foxp3 were BIO regulated (Fig-
ure 3F). Altogether, these data demonstrate that a considerable
proportion of Foxp3-bound genes are also bound by b-catenin
and, correspondingly, regulated by Wnt signaling.
Active Wnt Signaling Abrogates the Suppressive
Capacity of Treg Cells
Becausewe observed that b-catenin/TCF1 could regulate Foxp3
transcriptional targets, we further assessed the role of Wnt
signaling in Treg cell function. To analyze this, we performed
in vitro suppression assays by culturing sorted human Treg
cells along with carboxyfluorescein succinimidyl ester (CFSE)-
labeled peripheral bloodmononuclear cells (PBMCs). Our results
show a Treg:Teff ratio at which Treg-mediated suppression of
approximately 50%, given that such a ratio allows for an optimal
window for assessing increased or decreased Treg cell function
(Figures S4A and S4B). All Wnt mimetics used significantly
impaired Treg-cell-suppressive function in vitro, suggesting that
Wnt signaling in Treg cells abrogates their suppressive capacity
(Figures 4A and S4C). Importantly, there was no direct effect of
these inhibitors on PBMC proliferation (Figure 4B). To further
confirm that these results were Treg cell specific, Treg cells
were preincubated with Wnt mimetics, washed, and analyzed
for their suppressive capacity in the absence of inhibitors during
the assay. Pretreatment also abrogated Treg-cell-mediated
suppression of CD4+ T cell proliferation, confirming our previous
observations (Figures 4C and S4D). Comparable results were
observed for the CD8+ T cell population (data not shown).
Wnt proteins are unstable and notoriously difficult to purify;
however, to determine the effect of direct addition of Wnt302 Immunity 39, 298–310, August 22, 2013 ª2013 Elsevier Inc.protein on Treg-cell-suppressive capacity, we added purified
Wnt3a protein or IWP-2 during the suppression assays. IWP-2
is a specific inhibitor of the membrane-bound O-acyltransferase
Porcn, which facilitates the palmitoylation of Wnt and thereby
prevents Wnt processing and secretion (Willert et al., 2003).
The addition of Wnt3a significantly impaired Treg-cell-mediated
suppression (Figures 4D and S4E), whereas IWP-2-mediated
inhibition of Wnt production resulted in significantly increased
Treg-cell-suppressive capacity. Importantly, treatment with
Wnt3a or IWP-2 did not directly affect T cell proliferation (Fig-
ure 4E). To confirm that these results were a direct effect on
Treg cells, we pretreated cells with Wnt3a or IWP-2, and, after
washing, Treg cells were cultured with the CFSE-labeled PBMCs
for 4 days. Although to a lesser degree, Wnt3a pretreatment
inhibited Treg-cell-mediated suppression, validating our previ-
ous observations (Figures 4F and S4F). However, IWP-2 pre-
treatment did not increase Treg-cell-mediated suppression,
suggesting that Wnt is most likely produced by the PBMCs in
this experimental setup. To further assess the effect of Wnt
proteins on Treg cell function, we performed a suppression
assay in the presence of FZ8CRD, a soluble truncated Wnt
receptor that inhibits Wnt signaling. Again, the suppression of
Wnt signaling by the addition of FZ8CRD resulted in increased
Treg-cell-suppressive capacity (Figures 4G and S4G). Collec-
tively, these data suggest that Wnt is most likely produced by
mononuclear cells during in vitro suppression assays and that
the activation of the Wnt pathway diminishes the suppressive
functionality of Treg cells.
To assess the role of canonical Wnt signaling in modulating
Treg cell functionality in vivo, we used an established mouse
colitis model (Mottet et al., 2003). In this model, colitis was
induced by the infusion of CD4+CD45RB+ T cells into immuno-
deficient Rag1/ mice, and disease severity was diminished
by the adoptive transfer of Treg cells. Here, sorted Treg cells
from Foxp3-GFP mice were pretreated with BIO (in order to
activate TCF) or MeBIO and transferred to donor mice 3 weeks
after the transfer of naı¨ve CD4+ cells. An additional 3 weeks af-
ter Treg cell treatment, substantial colitis scores were observed
in mice that did not receive Treg cells, and infusion with control
(MeBIO)-treated Treg cells dramatically decreased colitis
scores (Figures 4H and 4I). Importantly, Treg cells pretreated
with BIO did not exhibit reduced colitis scores, indicating that
TCF activation abrogated Treg cell function in vivo. The per-
centage of GFP+ T cells in the spleen and mesenteric lymph
nodes (MLNs) were similar in all groups, indicating that
treatment with Wnt mimetic did not influence either Treg cell
homing or survival (Figures S4H and S4I). Furthermore, AXIN2
expression in sorted GFP+ Treg cells from the MLNs and
spleen of these mice was still increased in BIO-treated Treg
cells in comparison to MeBIO-treated Treg, indicating that
Wnt signaling was still more active in the BIO-treated Treg cells
at the end of the experiment (Figure S4J). To validate that
transient stimulation with BIO can indeed affect Treg cell
functionally for a sustained period, we transiently treated Treg
cells with BIO and cultured them without BIO for 5 days. Sub-
sequently, Treg-cell-mediated suppression was analyzed in an
in vitro suppression assay. Suppression of the BIO-pretreated
Treg cells was impaired in comparison to MeBIO-treated
Treg cells, indicating that transient activation of Wnt signaling
Figure 4. Wnt Signaling Regulates Treg Cell
Function
Human T cell suppression assays were performed in
order to analyze Treg-cell-mediated suppression.
Sorted CD4+CD25highCD127low Treg cells were co-
cultured with CFSE-labeled PBMCs in anti-CD3-
coated wells for 4 days. CFSE dilution of CD4s cells
was analyzed with FACS.
(A) Suppression by Treg cells in the presence of
TCF activators LiCl (5 mM), SB216763 (10 mM), BIO
(100 nM), or control MeBIO (100 nM) was analyzed.
(B) Human PBMCs were CFSE labeled and cultured in
the presence of 5 mM LiCl, 10 mM SB216763, 100 nM
BIO, and 100 nMMeBIO for 4 days in anti-CD3-coated
wells. The proliferation of CD4+ cells was analyzed by
CFSE dilution.
(C) Sorted Treg cells were preincubated with 10 mM
LiCl, 40 mM SB216763, 5 or 10 mM BIO, or 10 mM
MeBIO for 1 hr, washed, and functionality analyzed by
suppression assay.
(D) Suppression of Treg cells in the presence of Wnt3a
(400 ng/ml) or Wnt production inhibitor IWP-2 (2 mM).
(E) Human PBMCs were CFSE labeled and cultured in
the presence of 400 ng/ml Wnt3a and 2 mM IWP-2 for
4 days in anti-CD3-coated wells. The proliferation of
CD4+ cells was analyzed by CFSE dilution.
(F) Sorted Treg cells were pretreated with Wnt3a
(800 ng/ml) or IWP-2 (4 mM) for one hour. Cells were
washed and used for suppression assay.
(G) Suppression assay as in (A), cells were cultured in
the presence of FZ8CRD.
(H and I) Colitis was induced by infusion of CD4+
CD45RBhigh cells into immunodeficient mice. At day
21, Treg cells that were preincubated with 10 mM BIO
or MeBIO for 1 hr were administered. At day 42, mice
were sacrificed, and sections of the colon were
analyzed and scored as described in the Experimental
Procedures. Mean + SEM is depicted. All experiments
were performed in triplicate and for at least three
independent donors.
See also Figure S4.
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(Figure S4K).
To extend our observations through a genetic approach,
we utilized Treg cells isolated from TCF1/ mutant mice. As
previously reported, the number of peripheral CD4+ T cells in
TCF1-deficient (Tcf1/) mice was significantly reduced (Fig-
ure S5A) (Staal et al., 2008; Verbeek et al., 1995). However, the
percentage of Treg cells was similar in Tcf1/ mice in compar-
ison to control mice (Figures 5A and S5B). Treg-cell-mediated
suppression in vitro was reproducibly and substantially
increased in Tcf1/ Treg cells in comparison to wild-type (WT)
Treg cells, demonstrating that the absence of TCF1 positivelyImmunity 39, 298–influences Treg-cell-mediated suppression
(Figure 5B). To confirm that these differences
in Treg-cell-mediated suppression observed
in the Tcf1/ Treg cells were the result of
disrupted Wnt signaling, we repeated the
assay in the presence of BIO. As previously
observed, Treg-cell-mediated suppression
was impaired by BIO treatment and wasincreased in Tcf1/ Treg cells (Figures 5C and S5C). However,
BIO treatment had no effect on Tcf1/ Treg cells, demon-
strating the specificity of this Wnt mimetic in activating TCF1-
mediated transcription and thereby inhibiting Treg cell function.
To further validate these observations, suppression assays
were performed with Apcmin/+ Treg cells. Apcmin/+ cells have
increased b-catenin levels and TCF transcriptional activity
because of mutations in Apc, a component of the b-catenin
destruction complex (Staal et al., 2008; Aberle et al., 1997;
Reya et al., 2003; Verbeek et al., 1995). The suppressive capacity
of Apcmin/+ Treg cells was impaired in comparison to Apc+/+
Treg cells (Figure 5D).310, August 22, 2013 ª2013 Elsevier Inc. 303
Figure 5. Wnt Signaling Regulates Treg Cell
Function
(A) CD4+ splenocytes from both WT and Tcf1/ mice
were analyzed for CD25 expression.
(B) In vitro T cell suppression assays were performed in
order to analyze Treg cell functionality. Sorted CD4+
CD25high Treg cells from WT or Tcf1/ mice were
cocultured with CFSE-labeled WT splenocytes in the
presence of soluble anti-CD3 for 4 days. CFSE dilution of
CD4+ cells was determined by FACS analysis.
(C) Suppression assay performed as in (B) with sorted
CD4+CD25high Treg cells from WT or Tcf1/ mice that
were cultured in the presence or absence of 100 nM BIO.
(D) Suppression assay as in (B) utilizing sorted CD4+
CD25high Treg cells from Apcmin/+ or Apc+/+ mice. All
results depicted are the means + SEM of at least three
independent experiments.
(E and F) Colitis was induced by coinfusion of CD4+
CD45RBhigh cells with CD4+CD25high Apcmin/+ or Apc+/+
Treg cells into immunodeficient mice. At day 42, mice
were sacrificed, and colitis scores were analyzed. Sec-
tions of the colon were analyzed and scored as described
in the Experimental Procedures. Mean + SEM is depicted.
All experiments were performed in triplicate and for at
least three independent donors.
See also Figure S5.
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mouse colitis model again with Apcmin/+ Treg cells that were co-
transferred with naı¨ve WT CD4 T cells. As shown in Figures 5E
and 5F, 6 weeks after transfer colitis, scores were significantly
increased in the group receiving Apcmin/+ Treg cells in compari-
son to the group that had received Treg cells derived from WT
mice. Altogether, these data demonstrate that increased Wnt
signaling also abrogates Treg cell function in vivo.
IncreasedWnt3a Production Is Associatedwith Arthritis
Given that the addition of Wnt3a significantly abrogated Treg
cell function, Wnt3a expression was analyzed in human CD4
T cells upon activation. We observed the expression of Wnt3a
in CD4+ T cells, and T cell activation with anti-CD3 and anti-
CD28 resulted in a 3-fold increase in Wnt3a mRNA expression
(Figure 6A). Treg cells are known to be present in high numbers
in the joints of arthritis patients; however, they are unable to
control local inflammation (Lindley et al., 2005; Viglietta et al.,
2004; Ehrenstein et al., 2004). Furthermore, we have previously
reported that Treg-cell-mediated suppression is reduced when
cocultured with synovial fluid mononuclear cells (SFMCs) from
arthritis patients in comparison to coculture with PBMCs (Weh-
rens et al., 2011). Because we observed that Wnt3a significantly304 Immunity 39, 298–310, August 22, 2013 ª2013 Elsevier Inc.impairs Treg cell function, we wanted to deter-
mine whether mononuclear cells at an inflam-
matory locus may produce Wnt3a and thereby
inhibit Treg cell functionality. PBMCs and
matched SFMCs were isolated from five juve-
nile idiopathic arthritis patients, and Wnt3a
mRNA levels were compared. We observed a
10-fold increase of Wnt3a in SFMCs in com-
parison to PBMCs from the same patient (Fig-
ure 6B). To determine whether the inhibition ofWnt production by SFMCs would therefore result in increased
Treg-cell-mediated suppression, we performed a suppression
assay with SFMCs by using donor-matched Treg cells in the
presence of the Wnt production inhibitor IWP-2. As previously
reported, Treg-cell-mediated suppression was reduced in Treg
cells from juvenile idiopathic arthritis (JIA) patients in comparison
to healthy controls (Figures 6C and S5D) (Wehrens et al., 2011).
Strikingly, when Wnt production was inhibited, Treg-cell-medi-
ated suppression in patient cells was comparable to that of
healthy controls. These data indicate that Wnt3a production at
the site of (auto)inflammation may locally dampen Treg-cell-
mediated suppression in these patients.
Because we observed that Wnt production was increased by
mononuclear cells of JIA patients and that the inhibition of Wnt
production could restore Treg-cell-mediated suppression, we
sought to modulate Wnt activation in a murine arthritis model.
To this end, we used a proteoglycan-induced arthritis mouse
model (Glant and Mikecz, 2004; Roord et al., 2008). Importantly,
this model is Treg dependent, given that the depletion of Treg
cells results in significantly increased arthritis scores (Roord
et al., 2008). Arthritis was induced by proteoglycan injections,
and arthritis scores were analyzed three times per week by a
visual scoring system of redness, swelling, and deformities of
Figure 6. Increased Wnt3a Production Is Associated with Arthritis
(A) Wnt3a mRNA levels were analyzed by qRT-PCR from CD4+ T cells that were sorted from human PBMCs and cultured overnight in the absence or presence of
anti-CD3- and anti-CD28-coated beads.
(B) Wnt3a mRNA levels were determined in PBMCs or SFMCs from five different JIA patients.
(C) In vitro T cell suppression assays were performed in order to analyze Treg cell functionality. Sorted CD4+CD25high Treg cells isolated from healthy control
PBMCs or arthritis patient SFMCs were cocultured with matched CFSE-labeled PBMCs or SFMCs in the presence of anti-CD3 for 4 days. IWP-2 was added in
order to inhibit Wnt production. CFSE dilution of CD4+ cells was determined by FACS analysis.
(D) Arthritis was induced by two injections of PG in DDA on day 0 and day 21. Mice were treated with 6 mg/kg BIO or MeBIO twice a week or 2 mg/kg BIO three
times a week, and disease was scored (six mice per group) as described in the Experimental Procedures.
(E) Mice with an arthritis score of at least 2 are depicted.
(F) Mean arthritis scores are shown.
(G) Mice I.P. injected with 6 mg/kg BIO or MeBIO were sacrificed 18 hr after injection. Treg cells isolated from the spleen were cocultured with CFSE-labeled
splenocytes in the presence of anti-CD3 for 4 days, and Treg-cell-mediated suppression was determined by CFSE dilution. Mean + SEM is depicted.
See also Figure S5.
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were subjected to intraperitoneal (I.P.) injections with low BIO
(2 mg/kg, three times per week), high BIO (6 mg/kg, two times
per week), or MeBIO (6 mg/kg, two times per week) as a control
(Figure 6D). In these experiments, relatively young (16 weeks old)
mice that do normally not develop arthritis after two proteogly-
can (PG) injections under these experimental conditions were
used. As expected, no mice developed arthritis in the control
group (MeBIO). However, arthritis was observed in five out of
six mice that received high BIO and in three out of six mice
of the low BIO group, demonstrating a dose-dependent effect
of Wnt mimetic on disease scores (Figures 6E and 6F). Impor-
tantly, mice that did not receive PG but were treated with high
BIO did not develop arthritis (data not shown). No significant
differences were observed in Foxp3+ percentages or mean
fluorescence intensity in the spleen, again demonstrating that
BIO treatment does not modulate either the number of Foxp3+
Treg cells or Foxp3 expression levels (Figures S5E and 5F).
To confirm that the increased arthritis scores in BIO-treated
mice could be the result of impaired Treg cell functionality, we
performed an ex vivo suppression assay. Foxp3-GFP mice
were sacrificed 18 hr after I.P. injection with BIO or MeBIO. Equal
numbers of GFP+ Treg cells were isolated from the spleen, and
Treg-cell-mediated suppression of untreated Teff cell prolifera-
tion was analyzed. The suppressive capacity of Treg cells from
BIO-treated mice was significantly impaired in comparison to
control-treated mice, indicating that the systemic activation of
Wnt signaling indeed abrogates Treg cell function (Figures 6G
and S5G). Altogether, these mouse models demonstrate that
Wnt signaling can abrogate Treg-cell-mediated suppression
in vivo, which can result in the onset of arthritis.
T cell activation and proliferation is necessary for clearing
infections; however, at the site of inflammation, activated
T cells have been reported to directly interact with Treg cells
(Mempel et al., 2006; Stern and Smith, 1986). Because extensive
or prolonged Treg cell activity would be detrimental for the
resolution of infection, we propose a model in which Wnt pro-
duction by mononuclear cells could modulate the strength of
the immune response. Here, Wnt-mediated activation of FZD
receptors expressed on Treg cells could dampen Treg-cell-
mediated immune suppression through the inhibition of Foxp3
transcriptional output. However, when uncontrolled, this would
potentially contribute to the development of autoimmunity
(Figure S6).
DISCUSSION
Although Wnt signaling has traditionally been studied in the
context of thymocyte development and stem cell biology (Staal
et al., 2008; Verbeek et al., 1995; Reya et al., 2003), we present
data demonstrating an important functional role in immune
regulation. The role of Wnt proteins in regulating peripheral
T cell function remains poorly understood. In recent studies
demonstrating that the Wnt pathway can modulate CD8+ T cell
responses, TCF1 deficiency was shown to limit the proliferation
of CD8+ effector T cells and impair differentiation toward a cen-
tral memory phenotype (Zhou et al., 2010; Gattinoni et al., 2009).
Furthermore, TCF1 was found to be a T-cell-specific tumor
suppressor for the development of lymphomas because of the306 Immunity 39, 298–310, August 22, 2013 ª2013 Elsevier Inc.repression of LEF1 (Tiemessen et al., 2012). The ablation of
b-catenin in mouse intestinal dendritic cells impaired their
ability to induce Treg cells (Manicassamy et al., 2010), although
a single study reported that retroviral transduction of a stabilized
b-catenin mutant resulted in increased Treg cell survival (Ding
et al., 2008). However, continuous high amounts of b-catenin
are not favorable, and it has been shown that the expression
of stabilized b-catenin in thymocytes can result in the develop-
ment of thymic lymphomas (Guo et al., 2007). Therefore,
interpreting experiments with the overexpression of stabilized
b-catenin mutants can be difficult. Here, we show that Wnt
signaling directly modulates Foxp3 activity and thereby Treg
cell function. We used (1) recombinant Wnt3a, (2) a Wnt pro-
duction inhibitor, (3) a Wnt antagonist, (4) multiple distinct
GSK3 inhibitors (Wnt mimetics), and (5) Apcmin/+ and TCF1/
mice to manipulate Wnt signaling in vitro and in vivo and
thereby robustly studied the mechanism underlying these
observations.
The role of Treg cells in autoimmunity has been extensively
studied, and, although IPEX is the result of severely reduced
number of Treg cells (Wildin et al., 2001; Bennett et al., 2001),
the observation that, in most autoimmune diseases, the number
of Treg cells is normal or even increased suggests that here
these Treg cells are in some way dysfunctional (Buckner, 2010;
Yan et al., 2010; Han et al., 2009). Treg-cell-suppressive capac-
ity is reported to be severely impaired in a variety of autoimmune
diseases, including psoriasis, multiple sclerosis, type 1 diabetes,
systemic lupus, and rheumatoid arthritis (Lindley et al., 2005;
Viglietta et al., 2004; Ehrenstein et al., 2004). Furthermore,
Treg-cell-mediated suppression was reported to be reduced
when cocultured with SFMCs from arthritis patients in compari-
son to PBMCs, suggesting that SFMCs can produce factors that
abrogate Treg cell functionality (Wehrens et al., 2011). Although
there are potentially multiple mechanisms by which Treg cell
suppressive capacity could be impaired, we demonstrate here
that Wnt3a production provides a possible explanation. The
suppressive capacity of Treg cells was increased when PBMCs
were cultured in the presence of the Wnt production inhibitor
IWP-2, suggesting that PMBCs can produce Wnt proteins,
thereby inhibiting Treg cell function. In support of this, we estab-
lished that CD4+ T cells do indeed produce Wnt3a, and this was
significantly increased upon activation. We also demonstrate
that mononuclear cells in the synovial fluid of JIA patients
produce almost ten times more Wnt3a than PBMCs from the
same donor. When Wnt production was inhibited in SFMCs,
Treg-cell-mediated suppression was comparable to that of
healthy controls. Altogether, we suggest that dysregulated
Wnt production in the synovium could inhibit Treg cell function,
leading to an uncontrolled immune response and inflammation,
as observed in juvenile idiopathic arthritis.
Using ChIP-seq and microarray experiments, we demonstrate
that Wnt signalling (b-catenin/TCF1) and Foxp3 share many
transcriptional targets and bind to common genomic regions.
Recently, Samstein et al. (2012) demonstrated that Foxp3
exploits a pre-existing enhancer landscape. Foxp3 was found
to bind preaccessible enhancers that were already occupied
by Foxp3 binding partners. Our data suggest that Foxp3
might have a similar relationship with TCF1-regulated enhancer
elements.
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LiCl significantly abrogates their suppressive capacity. Several
studies have reported that Li intake is strongly correlated with
an increased predisposition for autoimmunity. Li salts are used
for the treatment of manic depression, and case studies report-
ing the onset of psoriasis after treatment with Li date as far back
as 1972. The incidence of psoriasis secondary to Li treatment
has been reported to be from 1.8% to 6% (Chan et al., 2000;
Sarantidis and Waters, 1983). In addition to psoriasis, there are
multiple reports of onset of autoimmune thyroid disease as a
result of Li treatment (Calabrese et al., 1985; Thompson and
Baylis, 1986). Furthermore, rats immunized with rat thyroglobulin
and treated with Li showed significantly increased antithyro-
globulin levels in comparison to untreated littermates (Hassman
et al., 1985). Given that we have demonstrated that LiCl
treatment inhibits Treg-cell-mediated suppression in multiple
models, it is possible that increased autoimmunity phenotypes
observed in Li-treated patients are caused by abrogated Treg
cell function.
Collectively, these data demonstrate that Wnt signaling can
modulate Treg-cell-mediated suppression. Therefore, manipu-
lating Wnt signaling could provide a therapeutic strategy for
controlling inappropriate immune responses and autoimmune
diseases.
EXPERIMENTAL PROCEDURES
Antibodies, DNA Constructs, and Reagents
The following human antibodies were used: mouse anti-Foxp3 clone
PCH101 for fluorescence-activated cell sorting (FACS) analysis (eBioscience),
mouse anti-hemagglutinin (HA) clone 12CA5 (Santa Cruz Biotechnology),
mouse anti-FLAG (Sigma-Aldrich), mouse anti-b-catenin (BD Biosciences),
rabbit anti-b-catenin (Cell Signaling Technology), rabbit anti-TCF1 (Cell
Signaling), anti-CD4 (BioLegend), anti-CD25, anti-CD127, and anti-CD8
(all BD Biosciences). The following mouse antibodies were used: anti-TCR,
anti-CD4, anti-CD25, and anti-CD8 (all BD Biosciences). HA-Foxp3 was
cloned from MIGR1-Foxp3 (kindly provided by S. Sakaguchi) (Hori et al.,
2003) into pMT2 containing a HA-tag-generating pMT2-HA-Foxp3. FLAG-
Foxp3 and pRSV-NFATC/A were described previously (van Loosdregt et al.,
2010). IL2 promoter luciferase (Panomics) has been described previously.
pcDNA3 (Invitrogen), LiCl (Sigma-Aldrich), SB 216763 (Sigma-Aldrich), BIO
(Calbiochem), MeBIO (Calbiochem), and IWP-2 (Sigma-Aldrich) were all
used in this study. Recombinant Wnt3a protein was produced in Drosophila
S2 cells and purified with blue sepharose affinity and gel filtration chromatog-
raphy as described previously (Willert et al., 2003).
TF-TF Interaction Array
Human embryonic kidney (HEK) 293T cells were transfected with HA-Foxp3
or empty vector. Nuclear extract were prepared 48 hr after transfection, and
the array was screened according to the manufacturer’s protocol (Panomics).
Immunoprecipitation was performed with anti-HA-coupled beads (Sigma-
Aldrich).
Cell Culture and Luciferase Assays
HEK 293T cells were cultured and transfected as described previously (Beek-
man et al., 2012) In short, cells were maintained in Dulbecco’s modified
Eagle’s medium (Invitrogen) supplemented with 8% heat-inactivated fetal
calf serum (FCS), penicillin, and streptomycin (Invitrogen) at 37C and 5%
CO2. Cells were transfected with a mixture of 1.5 mg DNA and 7.5 ml polyethy-
lenimine overnight. For the luciferase assay, cells were transfected with 1.0 mg
IL-2 promoter luciferase reporter with 0.5 mg of pMT2-Foxp3, pcDNA3-
NFATC/A, or pcDNA3, 7 mg pMT2 empty vector, and 0.05 mg pRLTK Renilla
(Promega) in order to normalize for transfection efficiency. Cells were trans-
fected in a six-well plate, and, 3 days after transfection, the cells were lysedin 50 ml passive lysis buffer, insoluble cell debris was spun down, and the
supernatant fraction was assayed for luciferase activity with a Dual-Luciferase
Reporter Assay System (Promega).
Oligonucleotide Pull-Down Assay
In vitro translated TCF1 was incubated at 30C for 10 min with either 0.5 nmol
of the 50-biotinylated double-stranded binding sites. The following biotinylated
primers were utilized: Scrambled, GCAGGATCCCATGGGC; IL-2 promoter,
AAGAATAAATGTTTAGATTTGTTGATAAACAGGAAGTGT. Subsequently, oli-
gonucleotides were coupled to streptavidin-agarose beads (Sigma-Aldrich).
After incubation, the biotinylated oligonucleotide-coupled streptavidin beads
were washed at least six times with low-salt buffer containing 150 mM NaCl
and denatured in SDS sample buffer before being run on an SDS-acrylamide
gel. Then, the separated proteins were immunoblotted for TCF1 with specific
antibodies.
Proximity Ligation Assay
PLA detection was performed as described previously (van Loosdregt
et al., 2011). In short, iTreg cells were fixed with 3% paraformaldehyde for
10 minutes. Subsequently, cells were washed three times with PBS and
blocked for 30 minutes at 22C in PBS containing 10% normal donkey serum,
0.5% BSA, and 0.5% saponin. After blocking, cells were incubated for 60 min
at 22C with mouse anti-Foxp3 and rabbit anti-TCF1 in PBS containing 10%
normal donkey serum, 0.5%BSA, and 0.5% saponin. Cells were washed three
times with PBST (0.05% Tween) and incubated with the secondary mouse
PLUS and rabbit MINUS antibodies for 1.5 hours at 37C in the dark. Cells
were washed three times in PBST before detection of the probe with the
in situ PLA detection kit (Abnova). Cells were analyzed with a 633 objective
on a Zeiss LSM 710 fluorescence microscope.
Chromatin Immunoprecipitation
ChIP was performed as described previously (Engelen et al., 2011). An iTreg
cell pool of five different donors was crosslinked with 2mM disuccinimidyl glu-
tarate (Thermo Fisher Scientific) and 1% formaldehyde. Cells were lysed in
preimmunoprecipitation buffer (10 mM Tris, 10 mM NaCl, 3 mM MgCl2, and
1 mM CaCl2), chromatin was prepared, and ChIP was performed according
to the Millipore online protocol with 15 mg of antibodies against TCF1 or rabbit
IgG as a control. The following primers were used for analysis: forward
TTGGCCCTAATCTGACCTTTT and reverse GGTGCATAGGCAGGAATGAT.
For ChIP-seq, immunoprecipitated chromatin was sheared and end re-
paired, sequencing adaptors were ligated, and the library was amplified by
ligation-mediated PCR (LMPCR). After LMPCR, the library was purified and
checked for the proper size range and for the absence of adaptor dimers on
a 2% agarose gel, barcoded, and sequenced on a SOLiD/AB sequencer in
multiplexed way in order to produce 50 bp reads. Sequencing reads were
mapped against the reference genome (hg19 assembly, National Center for
Biotechnology Information build 37) with the Burrows-Wheeler Alignment
Tool. Multiple reads mapping to the same location and strand were collapsed
to single read, and only uniquely placed reads were used for peak calling. Cis-
genome was used for peak calling from the ChIP-seq data.
In Vitro Suppression Assays
Human
CD4+CD25highCD127low Treg cells were sorted from human PBMCs and
cocultured with PBMCs labeled with 2 mM CFSE (at ratios of 1:10, 1:5, 1:2,
and 1:1) in anti-CD3 (clone OKT3)-coated 96-well plates. Cells were cultured
for 4 days in RPMI medium supplemented with 10% FCS, 100 U/ml penicillin,
100 mg/ml streptomycin, and 53 105 M 2-bmercaptoethanol. Proliferation of
CD4+ cells was determined by measuring CFSE dilution with a FACSCANTO
Analyzer (BD Biosciences). Suppression was determined by a comparison of
the percentage of proliferating cells with or without Treg cells.
Mouse
CD4 T cells were isolated by magnetic-activated cell sorting frommice spleen,
and CD4+CD25+-sorted cells were added to CFSE-labeled splenocytes at a
ratio of 1:5. Cells were cultured in Iscove’s modified Dulbecco’s medium sup-
plemented with 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml
streptomycin, and 5 3 105 M 2-mercaptoethanol in the presence of 1 mg/ml
soluble anti-CD3 (clone 145-2C11, BD Pharmingen) for 4 days. To determineImmunity 39, 298–310, August 22, 2013 ª2013 Elsevier Inc. 307
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analyzed cell population with FACS.
Quantitative PCR
qPCR was performed as described previously (van Loosdregt et al., 2013).
mRNA was isolated with trizol according to the manufacturer’s protocol
(Invitrogen), cDNA synthesis was performed with an iScript cDNA Synthesis
Kit (Bio-Rad). cDNA samples were amplified with SYBR Green Supermix
(Bio-Rad) in a MyiQ Single-Color Real-Time PCR Detection System (Bio-
Rad) according to the manufacturer’s protocol. The primers used for qPCR
were: b2M forward: CCAGCAGAGAATGGAAAGTC reverse: GATGCTGCTTA
CATGTCTCG Wnt3a forward: TCACGCTCTCGGGGCGGACTC reverse: ACA
GCCAGCGACCACCAGATCGG Axin2 forward: AGCCAAAGCGATCTACAA
AAGG reverse: GGTAGGCATTTTCCTCCATCAC mAxin2 forward: AAGCCC
CATAGTGCCCAAAG reverse: GGGTCCTGGGTAAATGGGTG FZD1 forward:
GCTGCGGAGAGTTGCGCTCTCTA reverse: CGAGCCCAAGCCGCTTTCG
FZD3 forward: CGCCGGGGTCTGAGGATAGCA reverse: ACATGGGGCAC
ATTTGGCCAACA FZD6 forward: TCAGCGGCTTGTATCTTGTGCCA reverse:
TGGTCGAGCTTTTGCTTTTGCCTGA FZD7 forward: CTCTCCCAACCGCCT
CGTCGCA reverse: ACAGAGGCCCAGGGACGAAAGC FZD8 forward: GCA
TGGAGTGGGGTTACCTGTT reverse: ATGCCCTTACACAGCGGCAC FZD9
forward: CACCGTGGCGGTCTTCATGCTCAA reverse: CGGCCAGCTGCTA
TCTTGCGGT FZD10 forward: CACCTGGGCGCTCCAAGAAGAGG reverse:
ATACCGGGAAGCGAGGGAAGC TCF1 forward: GTGACAAAAGGCCCCTTT
CCGAC reverse: CACAGGCCTGGCTGATTCCTTGT TCF4 forward: TACAGA
GGCATGCCACCAGGACT reverse: TGGTGTCAGGTCCTCATCGTCA b-cate-
nin forward: GAAGGTGTGGCGACATATGCAGCT reverse: ATCCAAGGGGTT
CTCCCTGGGC. In order to quantify the data, the comparative Ct method
was used. Relative quantity was defined as 2-DDCt, and b2-microglobulin
was used as a reference gene.
Transgenic Mice
C57Bl/6 Tcf1/ mice were originally described by Verbeek et al. (1995). All
mice were kept in the specified pathogen-free breeding section of the Leiden
University Medical Center.
Proteoglycan-Induced Arthritis Mouse Model
PG was purified from human articular cartilage and removed during knee joint
replacement surgery by 4 M guanidinium chloride extraction, and the human
glycosaminoglycan side chains were depleted by digestion with chondroiti-
nase ABC. Arthritis was induced in BALB/c mice by two I.P. injections of
0.4 mg human deglycosylated PG in 2 mg of the synthetic adjuvant dimethyl
dioctadecyl ammonium bromide (DDA, Sigma-Aldrich) on days 0 and 21.
Mice were I.P. injected with low BIO (2 mg/kg, three times per week), high
BIO (6 mg/kg, two times per week), or MeBIO (6 mg/kg two times per week)
as a control from day 21. The onset and severity of arthritis were assessed
three times aweek in a blinded fashion by a visual scoring system as described
previously (Roord et al., 2008). In brief, the degree of joint swelling, redness,
and deformation of each paw (scored from zero to four) was determined to
express a total arthritis score. The mice were kept in the animal facility of the
Utrecht University under regular conditions. The experiments were approved
by the Animal Experiment Committee of Utrecht University.
Induced Colitis Mouse Model
Colitis experiments were performed as previously described (Zaiss et al.,
2013). Rag1/ mice were kept in the animal facility of the Utrecht University
under specific pathogen-free conditions. The experiments were approved
by the Animal Experiment Committee of Utrecht University. Immunodeficient
mice were injected with 3 3 105 CD4+CD45high cells in order to induce colitis.
After 21 days, 3 3 105 Treg cells isolated from Foxp3-GFP mice were pre-
treated with 10 mM BIO or MeBIO for 1 hr, washed, and injected intravenously
via the lateral tail vein. The mice were sacrificed 3 weeks later, and colons
were fixed in formalin for 24 hr, embedded in paraffin, cut, and stained by
hematoxylin and eosin. Scoring was performed according to Berg et al.
(1996). In brief, grade 0 is equivalent to no infiltration of mononucleated cells.
Grade 1 is equivalent to few foci of mononucleated cells and only a slight
depletion of goblet cells. Grade 2 is equivalent to many foci of mononucleated
cells, infiltration in the lamina propria but not yet in the submucosa, and a308 Immunity 39, 298–310, August 22, 2013 ª2013 Elsevier Inc.diminished numbers of goblet cells. Grade 3 is equivalent to strong infiltration,
also in the submucosa, epithelial hyperplasia, and a number of goblet cells
strongly diminished. Grade 4 is equivalent to transmural infiltration of mono-
nucleated cells, strong epithelial hyperplasia and strong goblet cell depletion.
Each segment of the colon (ascending, transverse, or descending) was given
an individual score, and the sum of these scores gave the overall histological
score for each mouse. The percentage of GFP+ cells in the spleen and MLNs
were analyzed by FACS.
Statistical Analysis
Statistical analysis was performed with the Mann-Whitney test (GraphPad
Prism). p < 0.05 was considered statistically significant.ACCESSION NUMBERS
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